This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib
Blood Cancer Journal Open Access 02 October 2015
-
BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report
Journal of Medical Case Reports Open Access 08 April 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythemia vera. Nature 2005; 434: 1144–1148.
Inami M, Yamaguchi H, Hasegawa S, Mitamura Y, Kosaka F, Kobayashi A et al. Analysis of the exon 12 and 14 mutations of the JAK2 gene in Philadelphia chromosome-positive leukemia. Leukemia 2007; e-pub ahead of print, 13 September 2007 (doi:10.1038/sj.leu.2404953).
Haq AU . Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia. Am J Hematol 1990; 35: 110–113.
Hussein K, Bock O, Seegers A, Flasshove M, Henneke F, Buesche G et al. Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation. Blood 2007; 109: 4106–4107.
Inami M, Inokuchi K, Okabe M, Kosaka F, Mitamura Y, Yamaguchi H et al. Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia. Leukemia 2007; 21: 1103–1104.
Bornhäuser M, Mohr B, Oelschlaegel U, Bornhäuser P, Jacki S, Ehninger G et al. Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis. Leukemia 2007; 21: 1824–1826.
James C, Delhommeau F, Marzac C, Teyssandier I, Le Couedic JP, Giraudier S et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia 2006; 20: 350–353.
Wahlin A, Golovleva I . Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia. Eur J Haematol 2003; 70: 240–241.
Kohno T, Amenomori T, Atogami S, Sasagawa I, Nakamura H, Kuriyama K et al. Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript. Br J Haematol 1996; 93: 389–391.
Roumier C, Daudignon A, Soenen V, Dupriez B, Wetterwald M, Lai JL et al. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders? Haematologica 1999; 84: 1075–1080.
Gaikwad A, Nussenzveig R, Liu E, Gottshalk S, Chang K, Prchal JT . In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele. Exp Hematol 2007; 35: 587–595.
Acknowledgements
This work was supported by the Fondation de France (Comité Leucémie) and the North West Cancéropole (Axe Onco-Hématologie).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cambier, N., Renneville, A., Cazaentre, T. et al. JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia 22, 1454–1455 (2008). https://doi.org/10.1038/sj.leu.2405088
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2405088